Cargando…
ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis
BACKGROUND: Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) has been identified as a putative cancer stem cell (CSC) marker in breast cancer. However, the clinicopathological and prognostic significance of this protein in breast cancer patients remains controversial. METHODS: This meta-analysis...
Autores principales: | Liu, Ying, Lv, Dong-lai, Duan, Jiang-jie, Xu, Sen-lin, Zhang, Jing-fang, Yang, Xiao-jun, Zhang, Xia, Cui, You-hong, Bian, Xiu-wu, Yu, Shi-cang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070403/ https://www.ncbi.nlm.nih.gov/pubmed/24938375 http://dx.doi.org/10.1186/1471-2407-14-444 |
Ejemplares similares
-
ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers
por: Chang, Bin, et al.
Publicado: (2009) -
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
por: Wang, Junrong, et al.
Publicado: (2016) -
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015) -
High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma
por: Xing, Yue, et al.
Publicado: (2014) -
Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)